How mixed vaccines will provide better protection against COVID related mortality
Dr Sanjay Mukundan, Joint Secretary of Association of Foreign Graduated Physicians, Kerala emphasis that with the increase in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVAXIN
CORBEVAX gets DCGI nod as a heterologous COVID-19 booster dose
People who are 18 years and above and have already taken two doses of either covishield or covaxin can now receive a dose of…
DCGI approves three COVID vaccines for kids aged above five years
The approval has been granted to covaxin, ZyCov-D and Corbevax
ICMR study has shown rise in antibodies post Covaxin booster dose: MoS Health tells RS
International data available on booster doses of AstraZeneca and Covishield suggests a three-to four-fold increase in antibody…
Mix & match of different vaccines is safe and elicits robust antibody response: AIG Hospitals’…
The first pilot study from India analysing COVAXIN – COVISHEILD mixed doses
- Advertisement -
Covaxin for children: Study demonstrates robust safety and immunogenicity in 2-18 volunteers
Covaxin is one of the first COVID-19 vaccines in the world to generate data in 2-18 year age group
Covaxin receives approval for emergency use in 12-18 years old children
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
IIL produces covaxin drug substance in record time
Output of Covaxin drug substance will be 3 to 4 million a month and from Dec will increase to 10 million a month
Mixing & matching of Covaxin-Covishield shows better result: ICMR
The study is yet to be peer reviewed
ICMR study finds Covaxin effective against COVID-19 Delta Plus variant
Covaxin showed a 65.2 per cent protection against the Delta variant in a double-blind, randomised, multi-centre, phase-III…